In continuation of my update on Metformin
Metformin may protect against liver cancer: Metformin, a widely used, well-tolerated drug prescribed for patients with diabetes, may protect against liver cancer, according to a new study.
Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label linagliptin and metformin hydrochloride. Show all posts
Showing posts with label linagliptin and metformin hydrochloride. Show all posts
Wednesday, April 11, 2012
Sunday, February 5, 2012
FDA Approves Jentadueto ((linagliptin/metformin hydrochloride)).....
In continuation of my update on linagliptin and metformin hydrochloride
U.S. Food and Drug Administration (FDA) has approved Jentadueto (linagliptin/metformin hydrochloride) tablets, a new tablet combining the dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, and metformin. Jentadueto provides a new, single-tablet treatment option, taken twice-daily, for patients who need to control their blood sugar. Linagliptin (5 mg, once-daily) is marketed in the U.S. as Tradjenta (linagliptin) tablets....
Subscribe to:
Posts (Atom)